Efficacy and Safety of Crizotinib in Advanced or Recurrent 
ALK-positive Non-small Cell Lung Cancer by Xiaoyan LI, Huayan XU, Fang GAO, Xun KANG, Juan ZHANG, Jing ZHAO, Yi LIN, Xiaoqing LIU

Subjects: Get full text

Frequency of EGFR Mutation and EML4-ALK fusion gene in Arab Patients with Adenocarcinoma of the Lung by Shafik Hanan Ezzat, Ashour Mohamed

Subjects: Get full text

EML4-ALK-positive lung adenocarcinoma presenting an unusual metastatic pattern in a 29-year-old woman who is alive and well in her third year follow up:A case report by Fatma Tokat, Handan Zeren, Pinar Barut, Sualp Tansan, Umit Ince

Subjects: “…EML4-ALK translocation…”
Get full text

Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer by Zihua Zou, Lige Wu, Xuezhi Hao, Yan Li, Li Liang, Yangchun Gu, Jianming Ying, Junling Li, Puyuan Xing

Subjects: “…EML4‐ALK…”
Get full text

Clinical Research of Crizotinib in Advanced Non-small Cell Lung Cancer by Haibo ZHU, Xiaoyu XU, Ling WANG

Subjects: Get full text

A case of lung adenocarcinoma harboring <it>EGFR</it> mutation and <it>EML4-ALK</it> fusion gene by Tanaka Hisashi, Hayashi Akihito, Morimoto Takeshi, Taima Kageaki, Tanaka Yoshihito, Shimada Michiko, Kurose Akira, Takanashi Shingo, Okumura Ken

Subjects: Get full text

A New Target in Non-small Cell Lung Cancer: EML4-ALK Fusion Gene by Huijuan WANG, Jing YUAN, Zhiyong MA

Subjects: “…EML4-ALK…”
Get full text

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer by Nobuhiro Asai, Toyoharu Yokoi, Etsuro Yamaguchi, Akihito Kubo

Subjects: Get full text

Clinical Meaning of EML4-ALK Fusion Gene in Non-small Cell Lung Cancer by Wei HAN, Minghong BI

Subjects: Get full text

A Case of Non-small Cell Lung Cancer Treated with Three ALK Inhibitors 
and Chemotherapy by Jue WANG, Xiaoyan XU, Yanyan SUN, Hui LI

Subjects: “…eml4-alk fusion gene…”
Get full text

Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer by Yongkuan Guo, Ran Zhang, Yiran Meng, Li Wang, Liuqing Zheng, Jian You

Subjects: Get full text

Tumor response to radiotherapy and expression of epidermal growth factor receptor mutation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrange... by Nadeem M. S. Nagi, Yasir A. M. Khair, Khamis H. Bakari, Mohamed N. Nagi, Fabian P. Mghanga

Subjects: Get full text

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib by Yuki Matsumura, Sho Inomata, Hikaru Yamaguchi, Hayato Mine, Hironori Takagi, Masayuki Watanabe, Yuki Ozaki, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Yutaka Shio, Hiroyuki Suzuki

Subjects: Get full text

Microtubule Association of EML4–ALK V3 Is Key for the Elongated Cell Morphology and Enhanced Migration Observed in V3 Cells by Savvas Papageorgiou, Sarah L. Pashley, Laura O’Regan, Kees R. Straatman, Andrew M. Fry

Subjects: “…EML4–ALK…”
Get full text

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment by Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Vadym Ivanchuk, Rosario García‐Campelo, Manuel Dómine Gómez, José M. Sánchez, Bartomeu Massutí, Noemi Reguart, Carlos Camps, Sandra Sanz‐Moreno, Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Magdalena Arnal, Dietmar Fernández‐Orth, Virginia Calvo, Víctor González‐Rumayor, Mariano Provencio, Atocha Romero

Subjects: Get full text

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients by Xilin Zhang, Yan Jiang, Huanming Yu, Hui Xia, Xiang Wang

Subjects: Get full text

Value of Immunohistochemical Methods in Detecting EML4-ALK Fusion Mutations: 
A Meta-analysis by Chang LIU, Lu CAI, Diansheng ZHONG, Jing WANG

Subjects: Get full text

EML4‐ALK‐Positive Ovarian Cancer With Intracranial Metastasis Responds to Lorlatinib: A Case Report and Literature Review by Qiongqian Li, Tongze Cai, Xiaoming Zheng, Shunrong Zhang, Chanjuan Li, Huang Tang, Zhiyong Yu, Jianlong Zhou

Subjects: “…EML4‐ALK fusion gene…”
Get full text

A novel double fusion of EML4-ALK and PLEKHA7-ALK contribute to rapid progression of lung adenocarcinoma: a case report and literature review by Zhongzhao Wang, Yang Luo, Heng Gong, Yang Chen, Hao Tang

Subjects: Get full text

Mutational Profiling by Next-Generation Sequencing in Patients with Metastatic Non-Small Cell Lung Carcinoma: Our Experience by Hitesh Deka, Neelakshi Mahanta, Naba Kumar Kalita, Bibhash Chandra Goswami

Subjects: Get full text